“Advancements in Molecular Diagnostics and Miniaturized Devices”
- The point of care infectious disease market is increasingly favoring molecular diagnostic technologies due to their high accuracy, sensitivity, and rapid turnaround times for detecting pathogens
- Miniaturized and portable diagnostic devices are becoming prevalent, enabling testing at or near the patient's bedside, in remote locations, and even for home-based care
- These advancements facilitate quick diagnosis and immediate treatment initiation, particularly crucial in managing infectious disease outbreaks
- For instance, the development of rapid PCR tests and lab-on-a-chip technologies has significantly expanded the capabilities of POC infectious disease testing
- In high-burden regions such as Sub-Saharan Africa, molecular POC tests are favored for detecting diseases such as HIV and TB, reducing diagnostic turnaround time
- Clinics and hospitals are incorporating molecular POC testing as a standard for infectious disease management
